Public Employees Retirement System of Ohio Boosts Stock Holdings in Waters Co. (NYSE:WAT)

Public Employees Retirement System of Ohio raised its stake in Waters Co. (NYSE:WAT) by 0.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,935 shares of the medical instruments supplier’s stock after acquiring an additional 219 shares during the period. Public Employees Retirement System of Ohio’s holdings in Waters were worth $5,343,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Compagnie Lombard Odier SCmA bought a new stake in shares of Waters in the second quarter worth about $37,000. CSat Investment Advisory L.P. boosted its stake in Waters by 212.5% during the second quarter. CSat Investment Advisory L.P. now owns 225 shares of the medical instruments supplier’s stock valued at $48,000 after buying an additional 153 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in Waters during the 3rd quarter valued at approximately $51,000. Thor Advisors LLC purchased a new position in Waters during the 3rd quarter valued at approximately $52,000. Finally, Private Capital Group LLC increased its stake in Waters by 92.0% in the 2nd quarter. Private Capital Group LLC now owns 288 shares of the medical instruments supplier’s stock worth $56,000 after acquiring an additional 138 shares during the last quarter. Institutional investors own 96.88% of the company’s stock.

WAT stock opened at $221.36 on Wednesday. Waters Co. has a 12 month low of $173.41 and a 12 month high of $255.21. The company has a 50-day moving average price of $216.80 and a 200 day moving average price of $214.37. The stock has a market cap of $14.29 billion, a PE ratio of 26.70, a P/E/G ratio of 2.64 and a beta of 1.04. The company has a current ratio of 2.25, a quick ratio of 1.63 and a debt-to-equity ratio of 11.40.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, October 29th. The medical instruments supplier reported $2.13 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $2.13. The firm had revenue of $577.28 million during the quarter, compared to analyst estimates of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. Waters’s quarterly revenue was down .1% compared to the same quarter last year. During the same period last year, the company earned $1.92 EPS. Sell-side analysts forecast that Waters Co. will post 8.83 EPS for the current year.

Several analysts have recently issued reports on the company. Stifel Nicolaus assumed coverage on Waters in a report on Thursday, November 14th. They set a “hold” rating and a $210.00 price objective on the stock. Needham & Company LLC reissued a “hold” rating on shares of Waters in a report on Tuesday, October 29th. TheStreet cut shares of Waters from a “b” rating to a “c+” rating in a research report on Tuesday, October 29th. Finally, Barclays downgraded shares of Waters from an “equal weight” rating to an “underweight” rating and decreased their price target for the company from $210.00 to $195.00 in a research note on Wednesday, October 9th. Six investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the stock. Waters presently has an average rating of “Hold” and an average price target of $208.76.

In other Waters news, Director Edward Conard sold 1,112 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $221.97, for a total value of $246,830.64. Following the transaction, the director now directly owns 68,510 shares in the company, valued at approximately $15,207,164.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Elizabeth B. Rae sold 29,326 shares of the company’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $213.12, for a total transaction of $6,249,957.12. Following the completion of the transaction, the senior vice president now owns 23,932 shares in the company, valued at $5,100,387.84. The disclosure for this sale can be found here. In the last quarter, insiders sold 35,775 shares of company stock worth $7,639,152. Insiders own 1.14% of the company’s stock.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading: What are the qualifications of a portfolio manager?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.